International Biotechnology Trust’s Iovance Biotherapeutics IOVA Stock Holding History

International Biotechnology Trust’s Portfolio IOVA Stock Details IOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$2.02M	Buy	445,000 +380,000	+585%	+$2.48M	0.68%	40
2023 Q2	$457K	Buy	65,000 +9,000	+16%	+$64.4K	0.14%	58
2023 Q1	$342K	Hold	56,000	–	–	0.1%	61
2022 Q4	$357K	Hold	56,000	–	–	0.11%	60
2022 Q3	$536K	Buy	56,000 +52,989	+1,760%	+$611K	0.17%	61
2022 Q2	$273K	Sell	3,011 -54,989	-95%	-$721K	2.85%	13
2022 Q1	$2.84M	Hold	58,000	–	–	0.64%	37
2021 Q4	$1.11M	Hold	58,000	–	–	0.25%	55
2021 Q3	$1.43M	Hold	58,000	–	–	0.34%	49
2021 Q2	$1.51M	Hold	58,000	–	–	0.4%	43
2021 Q1	$1.84M	Hold	58,000	–	–	0.49%	33
2020 Q4	$2.69M	Sell	58,000 -87,000	-60%	-$3.45M	0.74%	28
2020 Q3	$4.77M	Buy	+145,000	New	+$4.45M	1.54%	20
2019 Q3	–	Sell	-104,000	Closed	-$2.54M	–	60
2019 Q2	$2.54M	Buy	+104,000	New	+$1.57M	0.94%	28

Other funds holding IOVA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MFM

MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

International Biotechnology Trust's IOVA Position: Q3 2023 in Review

International Biotechnology Trust increased its Iovance Biotherapeutics (IOVA) stake by 585% in Q3 2023, buying an estimated $2.48M and bringing the position to 445,000 shares worth $2.02M. The position accounts for 0.68% of the portfolio, ranked #40.

International Biotechnology Trust first reported a position in IOVA in Q2 2019 and has held it in 14 quarters since. The position peaked at $4.77M in Q3 2020. 227 funds tracked by Wall St. Rank hold IOVA as of Q3 2023.

International Biotechnology Trust held 445,000 shares of Iovance Biotherapeutics worth $2.02M as of Q3 2023.
International Biotechnology Trust bought 380,000 Iovance Biotherapeutics shares in Q3 2023, an estimated $2.48M.
Iovance Biotherapeutics made up 0.68% of International Biotechnology Trust's portfolio in Q3 2023, its #40 holding.
International Biotechnology Trust first reported a position in Iovance Biotherapeutics in Q2 2019 and has held it in 14 quarters since.
International Biotechnology Trust's Iovance Biotherapeutics position peaked at $4.77M in Q3 2020.
227 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2023.

Based on International Biotechnology Trust's 13F filing for Q3 2023, filed 14 Nov 2023.